Daily funding roundup - April 6, 2016

Bright Health secured $80M Series A; FinanzCheck closed Series C funding; CrossChx recieved $15M

• Qool Therapeutics, Inc., a Menlo Park, CA-based developer of non-invasive therapeutic hypothermia device for targeted temperature management and exercise recovery, closed a seed funding round of undisclosed amount. An investor syndicate of angelMD led by orthopedic surgeon Michael Dillingham, MD, participated in the round.
  
  
• Projector, an innovator in adaptive messaging and push notifications, announced that it has raised $4.5 million in seed financing led by Baseline Ventures in participation with Freestyle Capital, SV Angel, IDG Ventures and True Ventures. Projector (currently in private beta) is a platform that helps developers and product teams expand their product experiences outside the confines of their app.  A syndicate of angels, including Owen Van Natta, Dick Costolo, Damien Weiss and Jeremy LaTrasse also participated in the round. The funding will be used to bring the development of the Projector service out of Beta and into new market segments.
  
  
• Digital investment manager Scalable Capital announced the signing of a Series A funding round of €7 million (approximately $8 million). The round was led by existing investors Holtzbrink Ventures, Peng T. Ong’s Monk’s Hill Ventures, The German Startups Group and MPGI. The new capital takes the total amount of funding for the Munich- and London-based startup to about €10.9 million, making it one of the best-funded fintech startups in Europe.
  
  
• Kyulux, Inc., a Fukuoka, Japan-based advanced materials startup that is commercializing the next generation of OLED display and lighting technology known as TADF (Thermally Activated Delayed Fluorescence), raised $13.5 million (¥1.5 Billion Japanese Yen) in Series A venture capital funding. The round was led by Samsung Venture Investment Corporation with participation from global OLED panel manufacturers Samsung Display, LG Display, Japan Display and JOLED, top tier Japanese venture capital funds, and a Japanese Government affiliated venture fund.
  
  
• Vasona Networks Inc., a San Jose, California, provider of platforms to enable mobile-network operators to provide better service to users, raised $14.6 million of Series C venture capital. With the new capital, Vasona has raised a total of $48 million. The fresh funds will support Vasona’s deployments at major network operators and drive R&D, the company said in a statement. Participants in the round include Bessemer Venture Partners, New Venture Partners and NexStar Partners.
  
  
• Joyowo.com completed its series B round of funding and managed to raise $15 million from Sequoia Capital China. Joyowo.com is a Hangzhou-based online human resources service firm. Round also saw the participation from other investors such as Tsing Ventures, Meridian Capital China and others.
  
  
• Columbus-based CrossChx Inc. raised its second round of $15 million in as many years while adding new investors as it continues a push to install its digital check-in system in hospitals nationwide. Columbus VC firm NCT Ventures joined fellow Columbus firm Drive Capital LLC in the Series C round, which also includes repeat investor Khosla Ventures of Menlo Park, California, and new investors SVB Capital – the venture investing arm of Silicon Valley Bank – and angel investing syndicate Moonshots Capital.
  
  
• Hamburg-based Finanzcheck, a consumer loans marketplace, closed €33 million (approximately $37.5 million) in Series C funding. The round was led by growth-investor HarbourVest, with participation by Acton Capital Partners, and existing backer Highland Europe. Finanzcheck says it will use the new capital to consolidate its claimed leadership position in Germany’s €70 billion consumer loan market, as well to accelerate growth and roll out new products.
  
  
• Lumos Pharma, a biotechnology company focused on developing therapeutics for orphan diseases, completed a $34 million Series B financing.  Lumos will use the proceeds for clinical trials and commercialization of its lead compound, LUM-001, for the treatment of Creatine Transporter Deficiency (CTD). Funding will also be used to further develop other therapeutics in the company's pipeline. Deerfield Management Company led the financing, and is joined by new investors Clarus Ventures and Roche Venture Fund, as well as existing investors New Enterprise Associates (NEA), Sante Ventures and Belgian pharmaceutical company, UCB.
  
  
• New health insurance startup Bright Health secured $80 million in Series A funding led by Bessemer Venture Partners and New Enterprise Associates (NEA), with participation by Flare Capital Partners and others. Bright Health will use the funding to support its nationwide rollout to the individual health insurance marketplace.

If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to mitos@vator.tv. 

Image source: webdesign.org